- $158.01m
- $406.20m
- $401.97m
- 67
- 71
- 41
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 407 | 476 | 688 | 827 | 402 |
Cost of Revenue | |||||
Gross Profit | 132 | 135 | 167 | 246 | 153 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 355 | 433 | 638 | 1,372 | 490 |
Operating Profit | 52.1 | 42.6 | 50.8 | -545 | -88 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25 | 18.3 | 34 | -582 | -132 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.2 | 16.4 | 33 | -479 | -111 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8.79 | 63.8 | 33 | -373 | -227 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.79 | 63.8 | 33 | -373 | -227 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.297 | 0.2 | 0.388 | -1.45 | -0.923 |
Dividends per Share |